Cargando…

TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma

Telomerase reverse transcriptase (TERT) activity is up-regulated in several types of tumors including glioblastoma (GBM). In the present study, 128 primary glioblastoma patients were examined for single nucleotide polymorphisms of TERT in blood and in 92 cases for TERT promoter mutations in tumors....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosrati, Mohamed Ali, Malmström, Annika, Lysiak, Malgorzata, Krysztofiak, Adam, Hallbeck, Martin, Milos, Peter, Hallbeck, Anna-Lotta, Bratthäll, Charlotte, Strandéus, Michael, Stenmark-Askmalm, Marie, Söderkvist, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599297/ https://www.ncbi.nlm.nih.gov/pubmed/26143636

Ejemplares similares

The sex‐dependent role of the androgen receptor in glioblastoma: results of molecular analyses
por: Łysiak, Małgorzata, et al.
Publicado: (2022)

Deletions on Chromosome Y and Downregulation of the SRY Gene in Tumor Tissue Are Associated with Worse Survival of Glioblastoma Patients
por: Łysiak, Małgorzata, et al.
Publicado: (2021)

Methylation associated with long- or short-term survival in glioblastoma patients from the Nordic phase 3 trial
por: Łysiak, Małgorzata, et al.
Publicado: (2022)

Sex Disparities in MGMT Promoter Methylation and Survival in Glioblastoma: Further Evidence from Clinical Cohorts
por: Smits, Anja, et al.
Publicado: (2021)

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis
por: Mosrati, Mohamed Ali, et al.
Publicado: (2015)

Do we really know who has an MGMT methylated glioma? Results of an international survey regarding use of MGMT analyses for glioma
por: Malmström, Annika, et al.
Publicado: (2020)

PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status
por: Roodakker, Kenney R., et al.
Publicado: (2016)

ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab
por: Ellegård, Sander, et al.
Publicado: (2019)

“Do I want to know it all?” A qualitative study of glioma patients’ perspectives on receiving information about their diagnosis and prognosis
por: Malmström, Annika, et al.
Publicado: (2020)

Optical Brain Biopsy with a Fluorescence and Vessel Tracing Probe
por: Richter, Johan, et al.
Publicado: (2021)

Activating FGFR1 Mutations in Sporadic Pheochromocytomas
por: Welander, Jenny, et al.
Publicado: (2017)

Oligomeric amyloid-β induces early and widespread changes to the proteome in human iPSC-derived neurons
por: Sackmann, Christopher, et al.
Publicado: (2020)

Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study
por: Ellegård, Sander, et al.
Publicado: (2022)

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
por: Tunthanathip, Thara, et al.
Publicado: (2021)

Aggregated Alpha-Synuclein Transfer Efficiently between Cultured Human Neuron-Like Cells and Localize to Lysosomes
por: Domert, Jakob, et al.
Publicado: (2016)

TDP-43 Is Efficiently Transferred Between Neuron-Like Cells in a Manner Enhanced by Preservation of Its N-Terminus but Independent of Extracellular Vesicles
por: Sackmann, Christopher, et al.
Publicado: (2020)

p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group.
por: Stenmark-Askmalm, M., et al.
Publicado: (1995)

Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death
por: Jangamreddy, Jaganmohan R., et al.
Publicado: (2015)

Genetic Alterations in Mitochondrial DNA Are Complementary to Nuclear DNA Mutations in Pheochromocytomas
por: Tabebi, Mouna, et al.
Publicado: (2022)

Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis
por: Karlsson, Elin, et al.
Publicado: (2015)

Correction to: Uranium and neptunium retention mechanisms in Gallionella ferruginea/ferrihydrite systems for remediation purposes
por: Krawczyk-Bärsch, Evelyn, et al.
Publicado: (2021)

Uranium and neptunium retention mechanisms in Gallionella ferruginea/ferrihydrite systems for remediation purposes
por: Krawczyk-Bärsch, Evelyn, et al.
Publicado: (2020)

Quality and Safety of Minimally Invasive Surgery: Past, Present, and Future
por: McCrory, Bernadette, et al.
Publicado: (2014)

Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma
por: Park, Chul-Kee, et al.
Publicado: (2014)

The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials
por: Karlsson, Elin, et al.
Publicado: (2013)

The Place and Prognostic Value of TERT Promoter Mutation in Molecular Classification in Grade II-III Glial Tumors and Primary Glioblastomas
por: Kaya Terzi, Neslihan, et al.
Publicado: (2022)

Intracellular distribution of amyloid beta peptide and its relationship to the lysosomal system
por: Zheng, Lin, et al.
Publicado: (2012)

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
por: Ma, Sirui, et al.
Publicado: (2020)

Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
por: Teske, Nico, et al.
Publicado: (2021)

Quantifying Intraoperative Workloads Across the Surgical Team Roles: Room for Better Balance?
por: Yu, Denny, et al.
Publicado: (2016)

Operating hurts: a study of EAES surgeons
por: Wells, Antonia C., et al.
Publicado: (2018)

Exposure of α-Synuclein Aggregates to Organotypic Slice Cultures Recapitulates Key Molecular Features of Parkinson's Disease
por: Moudio, Serge, et al.
Publicado: (2022)

Prognostic role of ALK-1 and h-TERT expression in glioblastoma multiforme: correlation with ALK gene alterations
por: Elsers, Dalia, et al.
Publicado: (2021)

TERT Promoter Alterations in Glioblastoma: A Systematic Review
por: Olympios, Nathalie, et al.
Publicado: (2021)

The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma
por: Yuan, Xiaotian, et al.
Publicado: (2017)

Binding of α-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes
por: Reyes, Juan F., et al.
Publicado: (2019)

MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
por: Olsson, Hans, et al.
Publicado: (2013)

TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
por: Tang, Feng, et al.
Publicado: (2023)

The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
por: Lee, Yujin, et al.
Publicado: (2017)

Human TERT promoter mutations as a prognostic biomarker in glioma
por: Powter, Branka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_spdo9barchr5i55hg534fitu77